Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists


1047 El Camino Real Suite 202
Menlo Park, CA 94025
(650) 918-6363
Website Company Summary Management Team

CEO: Gini Deshpande (7/08)

Outside board: (May no longer be on the board) Ted Driscoll (Claremont Creek Ventures Venture Partner) Harsh P Patel (Claremont Creek Ventures Director) Atul Butte (Carmenta Bioscience co-Founder)
Advisory board: Samuel R Saks (Jazz Pharmaceuticals Former CEO/Chairman) Ravi Mhatre (Lightspeed Venture Partners Partner)
Former outside board: Nagesh S Mhatre (The Halo Fund) Brad Webb (Claremont Creek Ventures Venture Partner)
Former advisory board: Corey S Goodman (Labrys Biologics executive officer)

Business description: NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success as it mission. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of raw human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases. NuMedii is initially using its Big Data technology to discover and de-risk new indications for safe, existing drugs. It plans to apply the same approach to discover and de-risk new molecular entities based on therapeutically relevant biological networks.
Partners include: Allergan ;  Aptalis Pharma

Rounds: 2
Recent Fundings: Mar 2015   Jun 2013
Capital raised: 5.35M
Last Round: 1.85M
Ownership: Private  
VCs include: Life Science AngelsClaremont Creek Ventures Seraph Group ;  The Stanford StartX Fund

Last Tweets


Last Mentions

Record updated: Feb 2017
Sector: Medical
Year Founded: 2011
Headcount: 11-25
Rounds: 2
Recent Fundings: Mar 2015   Jun 2013
Capital Raised: 5.35M
Last Round: 1.85M
Ownership: Private